PlainPharmaWatch

CMS Open Payments · Program Year 2024

Pharmaceutical Business Consultants Limited

Pharmaceutical Business Consultants Limited reported $59,424.79 across General Payments, Research, and Ownership to 43 physicians and teaching hospitals across 43 transactions.

$59.4K
All-tracks total
43
Transactions
43
Recipients
+$15.4K
General Payments vs PY2023

Pharmaceutical Business Consultants Limited reported $59,424.79 across all CMS Open Payments tracks (General + Research + Ownership) to 43 physicians and teaching hospitals in Program Year 2024 - ranking #1316 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $59,424.79, averaging $1.4K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer pharmaceutical-business-consultants-limited Pharmaceutical Business Consultants Limited

$59.4K · #1316/1,925 · 0.0% industry · PY2024

  • TOT $59.4K
  • RANK #1316
  • SHARE 0.0%
  • TXN 43
  • RCP 43
  • CAT 4
  • GEN $59.4K
  • ΔGEN +$15.4K
  • TOP1 25.7%
  • PY 2024

Nearest volume peer: Kairos Surgical Inc ($59.4K)

IZI Medical Products, LLC$59.6KNatus Medical Incorporated$59.5KKairos Surgical Inc$59.4KPharmaceutical Business Cons…$59.4KTrevena, Inc.$59.3K
All-tracks payment totals near Pharmaceutical Business Consultants Limited (CMS Open Payments PY2024)

Pharmaceutical Business Consultants Limited sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Pharmaceutical Business Consultants Limited's CMS-reported General Payments increased by $15.4K (+35.1%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: PHARMACEUTICAL BUSINESS CONSULTANTS LIMITEDPY2023: PHARMACEUTICAL BUSINESS CONSULTANTS LIMITEDPY2024: Pharmaceutical Business Consultants Limited. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$44.0KPY2024$59.4K
PY2023
$44,001.11
PY2024
$59,424.79

What the Data Shows for Pharmaceutical Business Consultants Limited

Rank #1316 of 1,925 companies in CMS Open Payments for 2024 belongs to Pharmaceutical Business Consultants Limited, which reported $59,424.79 across 43 transactions to 43 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $1.4K per transaction and $1.4K per recipient.

"Consulting Fee" leads the 4-category general-payment breakdown below at $53.7K (90.4% of General Payments, 31 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Consulting Fee" leads Pharmaceutical Business Consultants Limited's 4-category general-payment breakdown at $53.7K, 90.4% of the reported total.

Pharmaceutical Business Consultants Limited reports 4 general-payment categories - the top three are Consulting Fee (90.4%), Travel and Lodging (8.4%), and Charitable Contribution (0.7%). The remaining 1 category make up 0.5% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How Pharmaceutical Business Consultants Limited divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$53.7K2. Travel and Lodging$5.0K3. Charitable Contribution$400.004. Food and Beverage$322.14
Payment Type Amount Transactions
Consulting Fee $53.7K 31
Travel and Lodging $5.0K 8
Charitable Contribution $400.00 1
Food and Beverage $322.14 3

Recipient Concentration in General Payments

The five largest recipient relationships account for $56,200.09 (94.6%) of $59,424.79 in this company's General Payments records across 10 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Pharmaceutical Business Consultants Limited

The five named recipients with the highest reported General Payments from this company

HASSAN L MIR Dr$15.2KJOHN Tracy WATSON Dr$13.8KJOSHUA W HUSTEDT Dr$12.3KLLOYD CHAMPAGNE Dr$11.4KSTEVEN L MORAN Dr$3.5K
  1. 1

    HASSAN L MIR Dr

    $15,247.70 across 10 reported transactions

  2. 2

    JOHN Tracy WATSON Dr

    $13,813.62 across 10 reported transactions

  3. 3

    JOSHUA W HUSTEDT Dr

    $12,250.00 across 4 reported transactions

  4. 4

    LLOYD CHAMPAGNE Dr

    $11,388.77 across 5 reported transactions

  5. 5

    STEVEN L MORAN Dr

    $3,500.00 across 6 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Pharmaceutical Business Consultants Limited's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Pharmaceutical Business Consultants Limited.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Pharmaceutical Business Consultants Limited.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Pharmaceutical Business Consultants Limited's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.